Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Fig. 2.15 Mucinous <strong>carcinoma</strong> with infiltrative<br />
invasive pattern. Irregular glands lined by cells<br />
with malignant features infiltrate the stroma.<br />
A<br />
Fig. 2.16 Mucinous adeno<strong>carcinoma</strong> with expansile invasive pattern. A Note the complex glandular proliferation.<br />
B The glands are lined by cells that have highly atypical nuclei and some intracytoplasmic<br />
m u c i n .<br />
B<br />
pling of all macroscopically suspicious<br />
areas has been recommended.<br />
Histopathology<br />
In the absence of obvious infiltration of the<br />
s t roma, invasion is assumed if there are<br />
complex papillary areas or back-to-back<br />
glands lined by malignant-appearing cells<br />
with little or no discernible intervening<br />
s t roma. To qualify as frankly invasive,<br />
such areas should be at least 10 mm 2 a n d<br />
at least 3 mm in each of 2 linear dimensions<br />
{1613}. Altern a t i v e l y, invasion may<br />
be in the form of infiltrative glands, tubules,<br />
cords or cell nests. The stroma may<br />
resemble ovarian stroma or be desmoplastic.<br />
In most cases there are also are a s<br />
that are benign or borderline in a p p e a-<br />
rance {1147,1150,1228,2047,2401}. R a rel<br />
y, mucinous tumours contain areas of mucinous<br />
adenofibroma with malignant epithelial<br />
cells and foci of stromal invasion.<br />
Differential diagnosis<br />
The most important differential diagnosis<br />
of mucinous ovarian <strong>carcinoma</strong> is with<br />
metastatic mucinous <strong>carcinoma</strong> that may<br />
present clinically as a primary ovarian<br />
tumour. Most of these originate in the<br />
large intestine, appendix, pancreas, biliary<br />
tract, stomach or cervix {237,639,<br />
1587,1703,2377,2406,3200,3221}. Since<br />
this problem has been emphasized relatively<br />
recently, it is likely that early reports<br />
of the histological appearance and<br />
behaviour of ovarian mucinous <strong>carcinoma</strong>s<br />
have been contaminated by metastatic<br />
<strong>carcinoma</strong>s masquerading as prim<br />
a ry ovarian neoplasms (see Ta b l e<br />
2.03). Common features that favour a primary<br />
mucinous <strong>carcinoma</strong> are an expansile<br />
pattern of invasion and a complex<br />
papillary pattern {1614}. Common features<br />
favouring a metastatic mucinous<br />
<strong>carcinoma</strong> are bilaterality, a multinodular<br />
growth pattern microscopically, histological<br />
surface involvement by epithelial<br />
cells (surface implants) and vascular<br />
space invasion {1614}.<br />
Somatic genetics<br />
Tumour heterogeneity is common and<br />
p robably is a reflection of the pro g re s s i o n<br />
f rom benign to malignant neoplasia that<br />
occurs in the development of mucinous<br />
c a rc i n o m a s. Recent studies strongly suggest<br />
that in the sequence of malignant<br />
t r a n s f o rmation from benign and bord e r-<br />
line mucinous tumours to infiltrative carc i-<br />
noma intraepithelial (non-invasive) carc i-<br />
nomas and <strong>carcinoma</strong>s with purely expansile<br />
(not obvious) invasion re p re s e n t<br />
transitional stages of mucinous carc i n o-<br />
genesis {1613}. This hypothesis is a l s o<br />
s u p p o rted by recent molecular studies of<br />
genetic alterations in mucinous t u m o u r s<br />
{591,964,1755,1891}. An increasing frequency<br />
of codon 12/13 K R A S m u t a t i o n s<br />
in benign, borderline and carc i n o m a t o u s<br />
mucinous ovarian tumours has been<br />
re p o rted supporting the viewpoint that<br />
K R A S mutational activation is an early<br />
event in mucinous ovarian tumorigenesis.<br />
Mucinous borderline tumours have a<br />
higher frequency of K R A S mutations than<br />
that of mucinous cystadenomas but a<br />
lower rate than that of mucinous carc i n o-<br />
mas {591,1755,1891}. Using micro d i s-<br />
section, the same K R A S mutation has<br />
been detected in separate areas exhibiting<br />
diff e rent histological grades within the<br />
same neoplasm {591}.<br />
Prognosis and predictive factors<br />
Clinical criteria<br />
Stage I mucinous <strong>carcinoma</strong>s have an<br />
excellent prognosis. However, the prognosis<br />
in cases with extraovarian spread<br />
is very poor {1076,1228,1458,1613,2377,<br />
2401,3069}.<br />
Histopathological criteria<br />
With the exception of one recent series<br />
{3769}, grading of mucinous carc i n o m a s<br />
has not been shown to be predictive of<br />
behaviour or response to therapy independent<br />
of the surgical stage {1076,<br />
1228,1458,1613,2377,3069}. Infiltrative<br />
s t romal invasion proved to be biologically<br />
m o re aggressive than expansile invasion.<br />
If individual invasive foci are all less than<br />
10 mm 2 , they have been termed "micro i n-<br />
vasive," and cases with this finding have<br />
had a favourable outcome {1453,1613,<br />
1 9 8 7 , 2 0 4 7 , 2 4 0 1 , 2 7 1 3 } .<br />
Mucinous borderline tumour,<br />
intestinal type<br />
Definition<br />
Ovarian tumours of low malignant potential<br />
exhibiting an epithelial proliferation of<br />
mucinous type cells greater than that<br />
seen in their benign counterparts but<br />
without evidence of stromal invasion. The<br />
epithelial component resembles intestinal<br />
epithelium, almost always contains<br />
goblet cells, usually contains neuroendocrine<br />
cells and rarely contains Paneth<br />
cells.<br />
Synonyms<br />
Mucinous tumour of low malignant potential,<br />
intestinal type; mucinous tumour of<br />
borderline malignancy, intestinal type.<br />
Epidemiology<br />
These account for 85-90% of mucinous<br />
borderline tumours.<br />
Macroscopy<br />
Mucinous borderline tumours of intestinal<br />
type are bilateral in approximately 5% of<br />
cases and usually are large, multilocular<br />
or unilocular cystic masses containing<br />
w a t e ry or viscous mucoid material.<br />
Surface epithelial-stromal tumours 125